Autopsy report · NCT05250856

CNP-201 in Subjects With Peanut Allergy

“Lagging Enrollment and Administrative Reasons”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 9 months before it stopped.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

COUR Pharmaceutical Development Company, Inc.

Sponsor type

Industry

Conditions

Peanut Allergy

Interventions

CNP-201; Placebo

Participants

15

Sites

17

Countries

United States

Trials that died the same way

• Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)
  “administrative reasons (slow patient enrollment)” (79% match in meaning)
• Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions
  “Slow enrollment, lack of follow up” (79% match in meaning)
• A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
  “Slow enrollment” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.